RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing Search

Search the Pharmalicensing out-licensing directory by keyword. Alternatively our advanced search allows you to query by industry sector, therapeutic target and development phase.
 
Industry sector Therapeutic target
Development phase
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Most Viewed

25 and 50 mg diclofenac K film coated immediate release tablets More
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More

Recently Added

Topical Diclofenac formulations for the treatment of inflammatory and painful conditions More
Fentanyl patch for the management of severe pain in patients who require continuous opioid analgesia. More
Transdermal system for mild to moderate dementia of the Alzheimer's type and for management of mild to moderate dementia associated with Parkinson 's disease. More
Novel splice variants of ErbB ligands for treating ErbB receptor-mediated diseases such as cancer. Receptor tyrosine kinases play a key role in the dissemination of cell to cell signaling in organisms, typically upon activation via specific activating... More
A novel diagnostic technology for urinary tract infection. Infectious diseases remain one of the greatest challenges to global health. Urinary tract infection (UTI) is considered to be the most common bacterial infection and poses a significant... More
Pharmalicensing recommends...


Unique cancer vaccine platform technology available for the development of new products
Our UK based company has developed a cancer vaccine platform technology, utilising dendritic cells, and is now looking to identify companies who can use this technology to develop their own products. More

Technology for the preparation of Eptifibatide, a GP IIb/IIIa glycoprotein antagonist platelet aggregation inhibitor
Our client has patented an environmentally friendly, cost effective, simple and scalable solid phase synthesis process for preparation of pure Eptifibatide More

Infra-red 3D digital imaging, tomography and spectroscopy technology.
US based innovative start-up company is developing a unique 3D infrared digital imaging device for the early detection of breast cancer. More

Browse By

Help & Support

Find out how to use this section.
View the presentation.

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us